Logo image of WULF

TERAWULF INC (WULF) Stock Fundamental Analysis

NASDAQ:WULF - Nasdaq - US88080T1043 - Common Stock - Currency: USD

4.97  +0.08 (+1.64%)

Fundamental Rating

2

WULF gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. WULF has a bad profitability rating. Also its financial health evaluation is rather negative. WULF is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year WULF has reported negative net income.
In the past year WULF had a positive cash flow from operations.
WULF had negative earnings in each of the past 5 years.
In the past 5 years WULF reported 4 times negative operating cash flow.
WULF Yearly Net Income VS EBIT VS OCF VS FCFWULF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M -250M

1.2 Ratios

Looking at the Return On Assets, with a value of -14.73%, WULF is doing worse than 66.67% of the companies in the same industry.
WULF has a Return On Equity of -72.74%. This is in the lower half of the industry: WULF underperforms 73.76% of its industry peers.
Industry RankSector Rank
ROA -14.73%
ROE -72.74%
ROIC N/A
ROA(3y)-19.15%
ROA(5y)-19.16%
ROE(3y)-46.79%
ROE(5y)-44.08%
ROIC(3y)N/A
ROIC(5y)N/A
WULF Yearly ROA, ROE, ROICWULF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

The Gross Margin of WULF (44.89%) is worse than 70.92% of its industry peers.
In the last couple of years the Gross Margin of WULF has grown nicely.
The Profit Margin and Operating Margin are not available for WULF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y12.53%
WULF Yearly Profit, Operating, Gross MarginsWULF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

1

2. Health

2.1 Basic Checks

WULF does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WULF has been increased compared to 1 year ago.
The number of shares outstanding for WULF has been increased compared to 5 years ago.
WULF has a worse debt/assets ratio than last year.
WULF Yearly Shares OutstandingWULF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
WULF Yearly Total Debt VS Total AssetsWULF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.88, we must say that WULF is in the distress zone and has some risk of bankruptcy.
WULF has a Altman-Z score of 0.88. This is in the lower half of the industry: WULF underperforms 64.18% of its industry peers.
A Debt/Equity ratio of 2.87 is on the high side and indicates that WULF has dependencies on debt financing.
WULF's Debt to Equity ratio of 2.87 is on the low side compared to the rest of the industry. WULF is outperformed by 81.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF N/A
Altman-Z 0.88
ROIC/WACCN/A
WACC10.23%
WULF Yearly LT Debt VS Equity VS FCFWULF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

WULF has a Current Ratio of 1.90. This is a normal value and indicates that WULF is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.90, WULF is in line with its industry, outperforming 58.87% of the companies in the same industry.
WULF has a Quick Ratio of 1.90. This is a normal value and indicates that WULF is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.90, WULF perfoms like the industry average, outperforming 59.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.9
WULF Yearly Current Assets VS Current LiabilitesWULF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

7

3. Growth

3.1 Past

WULF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.00%.
WULF shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.85%.
WULF shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.38% yearly.
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
Revenue 1Y (TTM)31.85%
Revenue growth 3YN/A
Revenue growth 5Y51.38%
Sales Q2Q%-18.92%

3.2 Future

The Earnings Per Share is expected to grow by 46.16% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 38.04% on average over the next years. This is a very strong growth
EPS Next Y-84.61%
EPS Next 2Y16.93%
EPS Next 3Y69.84%
EPS Next 5Y46.16%
Revenue Next Year40.09%
Revenue Next 2Y60.41%
Revenue Next 3Y54.72%
Revenue Next 5Y38.04%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
WULF Yearly Revenue VS EstimatesWULF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
WULF Yearly EPS VS EstimatesWULF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WULF. In the last year negative earnings were reported.
Also next year WULF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WULF Price Earnings VS Forward Price EarningsWULF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WULF Per share dataWULF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

WULF's earnings are expected to grow with 69.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.93%
EPS Next 3Y69.84%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WULF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TERAWULF INC

NASDAQ:WULF (7/14/2025, 12:16:08 PM)

4.97

+0.08 (+1.64%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-11 2025-08-11/bmo
Inst Owners53.38%
Inst Owner Change0%
Ins Owners9.34%
Ins Owner Change-1.1%
Market Cap1.90B
Analysts81.18
Price Target6.91 (39.03%)
Short Float %31.49%
Short Ratio2.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-131.18%
Min EPS beat(2)-133.63%
Max EPS beat(2)-128.73%
EPS beat(4)0
Avg EPS beat(4)-110.63%
Min EPS beat(4)-133.63%
Max EPS beat(4)-63.4%
EPS beat(8)0
Avg EPS beat(8)-105.17%
EPS beat(12)1
Avg EPS beat(12)-117.89%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.36%
Min Revenue beat(2)-21.8%
Max Revenue beat(2)-8.92%
Revenue beat(4)0
Avg Revenue beat(4)-13.73%
Min Revenue beat(4)-22.6%
Max Revenue beat(4)-1.59%
Revenue beat(8)0
Avg Revenue beat(8)-12.23%
Revenue beat(12)1
Avg Revenue beat(12)-25.53%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.76%
PT rev (3m)-20.79%
EPS NQ rev (1m)3.76%
EPS NQ rev (3m)-102.39%
EPS NY rev (1m)-53.32%
EPS NY rev (3m)-186.57%
Revenue NQ rev (1m)0.92%
Revenue NQ rev (3m)-15.61%
Revenue NY rev (1m)1.42%
Revenue NY rev (3m)-17.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.42
P/FCF N/A
P/OCF 206.55
P/B 11.18
P/tB 11.18
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.8
FCFYN/A
OCF(TTM)0.02
OCFY0.48%
SpS0.34
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.73%
ROE -72.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.89%
FCFM N/A
ROA(3y)-19.15%
ROA(5y)-19.16%
ROE(3y)-46.79%
ROE(5y)-44.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y12.53%
F-Score4
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 504.63%
Cap/Sales 238.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.9
Quick Ratio 1.9
Altman-Z 0.88
F-Score4
WACC10.23%
ROIC/WACCN/A
Cap/Depr(3y)536.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)235.52%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
EPS Next Y-84.61%
EPS Next 2Y16.93%
EPS Next 3Y69.84%
EPS Next 5Y46.16%
Revenue 1Y (TTM)31.85%
Revenue growth 3YN/A
Revenue growth 5Y51.38%
Sales Q2Q%-18.92%
Revenue Next Year40.09%
Revenue Next 2Y60.41%
Revenue Next 3Y54.72%
Revenue Next 5Y38.04%
EBIT growth 1Y-407.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year256.59%
EBIT Next 3Y118.84%
EBIT Next 5Y102.14%
FCF growth 1Y-330.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.34%
OCF growth 3YN/A
OCF growth 5YN/A